TY  - JOUR
AU  - Kurokawa, Shunya
AU  - Nomura, Kensuke
AU  - Hosogane, Nana
AU  - Nagasawa, Takashi
AU  - Kawade, Yuko
AU  - Matsumoto, Yu
AU  - Morinaga, Shuichi
AU  - Kaise, Yuriko
AU  - Higuchi, Ayana
AU  - Goto, Akiko
AU  - Inada, Naoko
AU  - Kodaira, Masaki
AU  - Kishimoto, Taishiro
PY  - 2024
DA  - 2024/2/19
TI  - Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study
JO  - J Med Internet Res
SP  - e51749
VL  - 26
KW  - acceptability
KW  - ADHD
KW  - application
KW  - attention-deficit/hyperactivity disorder
KW  - autism spectrum disorders
KW  - autism
KW  - child
KW  - children
KW  - diagnosis
KW  - management
KW  - neurodevelopmental disorder
KW  - neurodevelopmental
KW  - psychiatrists
KW  - reliability
KW  - telepsychitatry
AB  - Background: Given the global shortage of child psychiatrists and barriers to specialized care, remote assessment is a promising alternative for diagnosing and managing attention-deficit/hyperactivity disorder (ADHD). However, only a few studies have validated the accuracy and acceptability of these remote methods. Objective: This study aimed to test the agreement between remote and face-to-face assessments. Methods: Patients aged between 6 and 17 years with confirmed Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition diagnoses of ADHD or autism spectrum disorder (ASD) were recruited from multiple institutions. In a randomized order, participants underwent 2 evaluations, face-to-face and remotely, with distinct evaluators administering the ADHD Rating Scale-IV (ADHD-RS-IV). Intraclass correlation coefficient (ICC) was used to assess the reliability of face-to-face and remote assessments. Results: The participants included 74 Japanese children aged between 6 and 16 years who were primarily diagnosed with ADHD (43/74, 58%) or ASD (31/74, 42%). A total of 22 (30%) children were diagnosed with both conditions. The ADHD-RS-IV ICCs between face-to-face and remote assessments showed “substantial” agreement in the total ADHD-RS-IV score (ICC=0.769, 95% CI 0.654-0.849; P<.001) according to the Landis and Koch criteria. The ICC in patients with ADHD showed “almost perfect” agreement (ICC=0.816, 95% CI 0.683-0.897; P<.001), whereas in patients with ASD, it showed “substantial” agreement (ICC=0.674, 95% CI 0.420-0.831; P<.001), indicating the high reliability of both methods across both conditions. Conclusions: Our study validated the feasibility and reliability of remote ADHD testing, which has potential benefits such as reduced hospital visits and time-saving effects. Our results highlight the potential of telemedicine in resource-limited areas, clinical trials, and treatment evaluations, necessitating further studies to explore its broader application. Trial Registration: UMIN Clinical Trials Registry UMIN000039860; http://tinyurl.com/yp34x6kh 
SN  - 1438-8871
UR  - https://www.jmir.org/2024/1/e51749
UR  - https://doi.org/10.2196/51749
UR  - http://www.ncbi.nlm.nih.gov/pubmed/38373022
DO  - 10.2196/51749
ID  - info:doi/10.2196/51749
ER  -